Cel­gene and the sci­en­tist who cham­pi­oned fe­dra­tinib's rise from Sanofi's R&D grave­yard win FDA OK

Six years af­ter Sanofi gave it up for dead, the FDA has ap­proved the myelofi­bro­sis drug fe­dra­tinib, now owned by Cel­gene.

The drug will be sold as In­re­bic, and will soon land in the port­fo­lio at Bris­tol-My­ers Squibb, which is fi­nal­iz­ing a deal to ac­quire Cel­gene.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER